Neha Pandey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neha Pandey has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Sunit Kumar Singh
Banaras Hindu University
5 shared publications - Meghana Rastogi
Molecular Biology Unit, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India
3 shared publications - Astha Shukla
Molecular Biology Unit, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India
1 shared publication - Utkarsh Bhardwaj
Molecular Biology Unit, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India
1 shared publication
Latest Publications
- 5 November 2025
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 26 (5) , e228-e239
Kyasanur Forest disease: an emerging arboviral threat
- 5 November 2025
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 26 (5) , e228-e239
Kyasanur Forest disease: an emerging arboviral threat
- 24 March 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (2) , e70032
Biological and Pathogenic Blueprint of Chandipura Virus
Chandipura virus (CHPV) is a single‐stranded negative‐sense RNA virus of the family Rhabdoviridae . CHPV is transmitted mainly through infected sandflies. CHPV paediatric encephalitis reported in 2003–2004 in central and south‐western parts of India had a case fatality rate of ∼70%. CHPV infection leads to high‐grade fever, vomiting, altered sensorium, generalised convulsions, decerebrate posture and coma. Neuroinflammation is the hallmark of CHPV infection and has a pronounced effect on cerebral and brainstem regions. Currently, there are no vaccines or treatments available for CHPV infection. Although previous studies have provided insights into the virus's pathology and host‐pathogen interactions, the precise molecular mechanisms underlying CHPV pathogenesis are poorly understood. Understanding molecular pathogenesis is crucial for developing efficacious therapies and preventive measures. The review summarises CHPV epidemiology, transmission, genome structure, replication, pathogenesis and the latest antiviral therapies and vaccine developments.
- 24 March 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (2) , e70032
Biological and Pathogenic Blueprint of Chandipura Virus
Chandipura virus (CHPV) is a single‐stranded negative‐sense RNA virus of the family Rhabdoviridae . CHPV is transmitted mainly through infected sandflies. CHPV paediatric encephalitis reported in 2003–2004 in central and south‐western parts of India had a case fatality rate of ∼70%. CHPV infection leads to high‐grade fever, vomiting, altered sensorium, generalised convulsions, decerebrate posture and coma. Neuroinflammation is the hallmark of CHPV infection and has a pronounced effect on cerebral and brainstem regions. Currently, there are no vaccines or treatments available for CHPV infection. Although previous studies have provided insights into the virus's pathology and host‐pathogen interactions, the precise molecular mechanisms underlying CHPV pathogenesis are poorly understood. Understanding molecular pathogenesis is crucial for developing efficacious therapies and preventive measures. The review summarises CHPV epidemiology, transmission, genome structure, replication, pathogenesis and the latest antiviral therapies and vaccine developments.
- Open Access
- 7 July 2021
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 28 (1) , 1-13
Chandipura virus dysregulates the expression of hsa-miR-21-5p to activate NF-κB in human microglial cells
Background: Chandipura virus (CHPV) is a negative single-stranded RNA virus of the Rhabdoviridae family. CHPV infection has been reported in Central and Western India. CHPV causes acute encephalitis with a case fatality rate of 70 % and mostly affects children below 15 years of age. CHPV infection in brain leads to neuronal apoptosis and activation of the microglial cells. The microRNAs (miRNAs) are small endogenous non-coding RNA that regulate the gene expression. Viral infections perturb the expression pattern of cellular miRNAs, which may in turn affect the expression pattern of downstream genes. This study aims to investigate hsa-miR-21-5p mediated regulation of PTEN, AKT, NF-ĸBp65, IL-6, TNF-α, and IL-1β, in human microglial cells during CHPV infection. Methods: To understand the role of hsa-miR-21-5p in CHPV infection, the human microglial cells were infected with CHPV (MOI-0.1). Real-time PCR, western blotting, Luciferase assay, over-expression and knockdown techniques were used to understand the role of hsa-miR-21-5p in the regulation of PTEN, AKT and, NF-ĸBp65, IL-6, TNF-α, and IL-1β in this study. Results: The hsa-miR-21-5p was found to be upregulated during CHPV infection in human microglial cells. This led to the downregulation of PTEN which promoted the phosphorylation of AKT and NF-ĸBp65. Over-expression of hsa-miR-21-5p led to the decreased expression of PTEN and promoted further phosphorylation of AKT and NF-ĸBp65 in human microglial cells. However, the inhibition of hsa-miR-21-5p using hsa-miR-21-5p inhibitor restored the expression. Conclusions: This study supports the role of hsa-miR-21-5p in the regulation of pro-inflammatory genes in CHPV infected human microglial cells.
- 7 July 2021
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 28 (1) , 1-13
Open AccessChandipura virus dysregulates the expression of hsa-miR-21-5p to activate NF-κB in human microglial cells
Background: Chandipura virus (CHPV) is a negative single-stranded RNA virus of the Rhabdoviridae family. CHPV infection has been reported in Central and Western India. CHPV causes acute encephalitis with a case fatality rate of 70 % and mostly affects children below 15 years of age. CHPV infection in brain leads to neuronal apoptosis and activation of the microglial cells. The microRNAs (miRNAs) are small endogenous non-coding RNA that regulate the gene expression. Viral infections perturb the expression pattern of cellular miRNAs, which may in turn affect the expression pattern of downstream genes. This study aims to investigate hsa-miR-21-5p mediated regulation of PTEN, AKT, NF-ĸBp65, IL-6, TNF-α, and IL-1β, in human microglial cells during CHPV infection. Methods: To understand the role of hsa-miR-21-5p in CHPV infection, the human microglial cells were infected with CHPV (MOI-0.1). Real-time PCR, western blotting, Luciferase assay, over-expression and knockdown techniques were used to understand the role of hsa-miR-21-5p in the regulation of PTEN, AKT and, NF-ĸBp65, IL-6, TNF-α, and IL-1β in this study. Results: The hsa-miR-21-5p was found to be upregulated during CHPV infection in human microglial cells. This led to the downregulation of PTEN which promoted the phosphorylation of AKT and NF-ĸBp65. Over-expression of hsa-miR-21-5p led to the decreased expression of PTEN and promoted further phosphorylation of AKT and NF-ĸBp65 in human microglial cells. However, the inhibition of hsa-miR-21-5p using hsa-miR-21-5p inhibitor restored the expression. Conclusions: This study supports the role of hsa-miR-21-5p in the regulation of pro-inflammatory genes in CHPV infected human microglial cells.
- Open Access
- 1 December 2020
- Published by Springer Nature in Respiratory Research
- Vol. 21 (1) , 1-15
SARS coronavirus 2: from genome to infectome
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the group of Betacoronaviruses. The SARS-CoV-2 is closely related to SARS-CoV-1 and probably originated either from bats or pangolins. SARS-CoV-2 is an etiological agent of COVID-19, causing mild to severe respiratory disease which escalates to acute respiratory distress syndrome (ARDS) or multi-organ failure. The virus was first reported from the animal market in Hunan, Hubei province of China in the month of December, 2019, and was rapidly transmitted from animal to human and human-to-human. The human-to-human transmission can occur directly or via droplets generated during coughing and sneezing. Globally, around 53.9 million cases of COVID-19 have been registered with 1.31 million confirmed deaths. The people > 60 years, persons suffering from comorbid conditions and immunocompromised individuals are more susceptible to COVID-19 infection. The virus primarily targets the upper and the lower respiratory tract and quickly disseminates to other organs. SARS-CoV-2 dysregulates immune signaling pathways which generate cytokine storm and leads to the acute respiratory distress syndrome and other multisystemic disorders.
- 1 December 2020
- Published by Springer Nature in Respiratory Research
- Vol. 21 (1) , 1-15
Open AccessSARS coronavirus 2: from genome to infectome
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the group of Betacoronaviruses. The SARS-CoV-2 is closely related to SARS-CoV-1 and probably originated either from bats or pangolins. SARS-CoV-2 is an etiological agent of COVID-19, causing mild to severe respiratory disease which escalates to acute respiratory distress syndrome (ARDS) or multi-organ failure. The virus was first reported from the animal market in Hunan, Hubei province of China in the month of December, 2019, and was rapidly transmitted from animal to human and human-to-human. The human-to-human transmission can occur directly or via droplets generated during coughing and sneezing. Globally, around 53.9 million cases of COVID-19 have been registered with 1.31 million confirmed deaths. The people > 60 years, persons suffering from comorbid conditions and immunocompromised individuals are more susceptible to COVID-19 infection. The virus primarily targets the upper and the lower respiratory tract and quickly disseminates to other organs. SARS-CoV-2 dysregulates immune signaling pathways which generate cytokine storm and leads to the acute respiratory distress syndrome and other multisystemic disorders.